Lynne V. Abruzzo, M.D., Ph.D. University of Texas MD Anderson Cancer Center

THERAPY/ PROGNOSTIC

Altered expression of genes other than ATM contributes to poor outcome in CLL patients with 11q deletions

No update is available at this time. Please check back soon.